Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:country |
gptkb:India
|
| gptkbp:focus |
advanced wound care
hemostatic solutions |
| gptkbp:foundedIn |
2008
|
| gptkbp:founder |
gptkb:Leo_Mavely
|
| gptkbp:headquartersLocation |
gptkb:Bangalore
|
| https://www.w3.org/2000/01/rdf-schema#label |
Axio Biosolutions
|
| gptkbp:industry |
medical devices
|
| gptkbp:investor |
gptkb:TrueScale_Capital
gptkb:University_of_California,_Ratan_Tata_Fund gptkb:Omidyar_Network_India |
| gptkbp:notableAchievement |
first Indian company to get US FDA clearance for wound dressing based on chitosan
|
| gptkbp:numberOfEmployees |
200+
|
| gptkbp:product |
gptkb:Axiostat
gptkb:MaxioCel |
| gptkbp:regionServed |
global
|
| gptkbp:regulates |
gptkb:US_FDA
gptkb:CE_Mark |
| gptkbp:website |
https://www.axiobio.com/
|
| gptkbp:bfsParent |
gptkb:Catamaran_Ventures
|
| gptkbp:bfsLayer |
6
|